Kezar Life Sciences Inc (KZR)
0.7891
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 16:00
0.7891
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Cash from Operations (TTM): -81.64M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -81.64M |
September 30, 2023 | -78.55M |
June 30, 2023 | -74.70M |
March 31, 2023 | -66.39M |
December 31, 2022 | -58.85M |
September 30, 2022 | -54.04M |
June 30, 2022 | -47.64M |
March 31, 2022 | -47.39M |
December 31, 2021 | -42.44M |
September 30, 2021 | -40.66M |
June 30, 2021 | -39.96M |
March 31, 2021 | -37.00M |
December 31, 2020 | -36.95M |
Date | Value |
---|---|
September 30, 2020 | -34.85M |
June 30, 2020 | -33.86M |
March 31, 2020 | -31.48M |
December 31, 2019 | -29.88M |
September 30, 2019 | -28.14M |
June 30, 2019 | -24.49M |
March 31, 2019 | -23.73M |
December 31, 2018 | -20.79M |
September 30, 2018 | -16.94M |
June 30, 2018 | -14.51M |
March 31, 2018 | -9.863M |
December 31, 2017 | -8.109M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-81.64M
Minimum
Dec 2023
-24.49M
Maximum
Jun 2019
-46.79M
Average
-40.66M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Accuray Inc | 19.82M |
Tonix Pharmaceuticals Holding Corp | -102.00M |
Acumen Pharmaceuticals Inc | -43.06M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |